KIF15 Activators represent a diverse group of chemicals primarily characterized by their ability to indirectly modulate the activity of the KIF15 protein, a molecular motor involved in mitotic spindle assembly and function. While not directly enhancing the action of KIF15, these activators often exert influence on cellular processes or pathways that KIF15 is intricately linked to, thus driving conditions where the protein's role becomes more pronounced or essential.
Among these chemicals, microtubule-targeting agents such as Taxol stabilize microtubules, facilitating an environment where KIF15 interactions with microtubules are accentuated. Conversely, agents like Vinblastine, Nocodazole, and Colchicine disrupt microtubule dynamics, affecting the equilibrium and dynamics of the mitotic spindle and indirectly emphasizing the importance of KIF15 in maintaining spindle integrity. Additionally, the presence of kinase inhibitors like MLN8237 (Alisertib), BI 2536, and ZM 447439 that target crucial proteins in mitotic progression can reshape the cellular landscape during mitosis, highlighting KIF15's role in spindle dynamics and proper chromosome segregation. Interestingly, specific kinesin inhibitors like Monastrol and S-Trityl-L-cysteine put a halt to other motor proteins like Eg5 kinesin. This halting creates a cellular demand where KIF15's function as a backup or alternate motor protein is accentuated.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Taxol | 33069-62-4 | sc-201439D sc-201439 sc-201439A sc-201439E sc-201439B sc-201439C | 1 mg 5 mg 25 mg 100 mg 250 mg 1 g | $41.00 $74.00 $221.00 $247.00 $738.00 $1220.00 | 39 | |
Stabilizes microtubules, possibly enhancing the interaction of KIF15 with microtubules. | ||||||
Vinblastine | 865-21-4 | sc-491749 sc-491749A sc-491749B sc-491749C sc-491749D | 10 mg 50 mg 100 mg 500 mg 1 g | $102.00 $235.00 $459.00 $1749.00 $2958.00 | 4 | |
Disrupts microtubule dynamics, potentially affecting KIF15's role in mitotic spindle assembly. | ||||||
Nocodazole | 31430-18-9 | sc-3518B sc-3518 sc-3518C sc-3518A | 5 mg 10 mg 25 mg 50 mg | $59.00 $85.00 $143.00 $247.00 | 38 | |
Microtubule depolymerizing agent, its presence might necessitate KIF15 activity for spindle recovery. | ||||||
Colchicine | 64-86-8 | sc-203005 sc-203005A sc-203005B sc-203005C sc-203005D sc-203005E | 1 g 5 g 50 g 100 g 500 g 1 kg | $100.00 $321.00 $2289.00 $4484.00 $18207.00 $34749.00 | 3 | |
Binds tubulin, preventing microtubule polymerization, which can indirectly modulate KIF15's function in spindle dynamics. | ||||||
MLN8237 | 1028486-01-2 | sc-394162 | 5 mg | $220.00 | ||
Aurora A kinase inhibitor, which affects spindle formation. This can influence KIF15's role in spindle dynamics. | ||||||
BI 2536 | 755038-02-9 | sc-364431 sc-364431A | 5 mg 50 mg | $151.00 $525.00 | 8 | |
Inhibits Polo-like kinase, which is crucial for mitosis. This can indirectly modulate KIF15 function. | ||||||
ZM-447439 | 331771-20-1 | sc-200696 sc-200696A | 1 mg 10 mg | $153.00 $356.00 | 15 | |
Aurora kinase inhibitor; by inhibiting Aurora kinase, it can affect KIF15's interactions in the spindle apparatus. | ||||||
RO-3306 | 872573-93-8 | sc-358700 sc-358700A sc-358700B | 1 mg 5 mg 25 mg | $66.00 $163.00 $326.00 | 37 | |
CDK1 inhibitor, which arrests cells in G2/M phase. This might modify the demand for KIF15 during mitosis. | ||||||